23
Views
14
CrossRef citations to date
0
Altmetric
Experimental and Clinical Research

Oxacillin- and Mupirocin-Resistant Staphylococcus aureus: In vitro Activity of Silver Sulphadiazine and Cerium Nitrate in Hospital Strains

Pages 453-458 | Published online: 18 Jul 2013

REFERENCES

  • Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci: epidemiology, mole-cular mechanisms and clinical relevance. Infect Dis Clin North Am 1997; 11: 813–841.
  • Kluytmans J, Van Belkum A, Verbrugh H. Nasal car-riage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10: 505–520.
  • Chang FY, Singh N, Gayowski T, Drenning SD, Wagener Mm, Marino IR. Staphylococcus aureus nasal colo-nization and association with infections in liver transplant recipients. Transplantation 1998; 65: 1169–1172.
  • Frebourg N, Cauliez B, Lemeland JF. Evidence for nasal carriage of methicillin-resistant staphylococci colonizing intravascular devices. J Clin Microbiol 1999; 37: 1182–1185.
  • Corbella X, Dominguez MA, Pujol M, et al. Staphylococcus aureus nasal carriage as a marker for subse-quent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997; 16: 351–357.
  • von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bac-teremia. N Engl J Med 2001; 344: 11–16.
  • Boyce JM. Preventing staphylococcal infections by erad-icating nasal carriage of Staphylococcus aureus: proceeding with caution. Infect Control Hosp Epidemiol 1996; 17: 775–779.
  • Santos KRN, Fonseca LS, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hos-pitals. Infect Control Hosp Epidemiol 1996; 17: 24–27.
  • Rich M, Bannatyne RM, Memish ZA. Mupirocin resis-tance of methicillin resistant Staphylococcus aureus in Saudi Arabia. J Chemother 1999; 11: 414–415.
  • Deshpande LM, Fix AM, Pfaller MA, Jones RN, SEN-TRY GROUP. Emerging elevated mupirocin resistance rates among staphylococal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, E-test and reference dilution methods. Diag Microbiol Infect Dis 2002; 42: 283–290.
  • Nunes ELC, Santos KRN, Mondino PJJ, Bastos MCF, Giambiagi-De-Marval M. Detection of ileS-2 gene encoding mupirocin resistance in methicillin-resistant Staphylococcus aureus by multiplex PCR. Diag Microbiol Infect Dis 1999; 34: 77–81.
  • Bastos MCF, Mondino PJJ, Azevedo MLB, Santos KRN, Giambiagi-Demarval M. Molecular characterization and transfer among Staphylococcus strains of a plasmid confering high-level resistance to mupirocin. Eur J Clin Microbiol Infect Dis 1999; 18: 393–398.
  • Fung S, O'Grady S, Kennedy C, Deider H, Campbell I, Conly J. The utility of polysporin ointment the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study. Infect Control Hosp Epidemiol 2000; 21: 653–655.
  • Kokai-Kum JF, Walsh SM, Chanturiya T, Mond JJ. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 2003; 47: 1589: 1597.
  • Fox CL. Silver sulfadiazine: A new topical therapy for Pseudomonas in burns. Arch Surg 1968; 96: 184–188.
  • Marone P, Monzillo V, Perversi L, Carreto E. Comparative in vitro activity of silver sulphadiazine alone and in combination with cerium nitrate against staphylococci and Gram-negative bacteria. J Chemother 1998; 10: 17–21.
  • Gracia CG. An open study comparing topical silver sul-fadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate an severe burns. Burns 2001; 27: 67–74.
  • Rosenkranz HS, Carr HS. Silver sulfadiazine: effect on the growth and metabolism of bacteria. Antimicrob Agents Chemother 1972; 2: 367.
  • Coward JE, Carr HS, Rosenkranz HS. Silver Sulphadiazine: effect on the growth and ultra structure of staphylococci. Chemotherapy 1973; 19: 348–353.
  • Monafo WW, Tandom SN, Tuchschmi DTJ, Skinner AM, Deitz F. Cerium nitrate: A new topical antiseptic for extensive burns. Surgery 1976; 80: 465–473.
  • Rosenkranz HS. A synergistic effect between cerium nitrate and silver sulphadiazine. Burns 1978; 5: 178–281.
  • Maple PA, Hamilton-Miller JMT, Brumfitt W. Comparison of the in vitro activities of the topical antimicro-bials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1992; 29: 661–668.
  • Hamilton-Miller JMT, Shah S, Smith C. Silver sulphadi-azine: a comprehensive in vitro reassessment. Chemotherapy 1993; 39: 405–409.
  • MacFaddin JF. Biochemical Tests for Identification of Medical Bacteria. Williams & Wilkins Company, Baltimore, USA. 1976: 312.
  • Holt GH, Krieg NR, Sneath PHA, Staley JT, Williams ST. Genus Staphylococcus. In: Bergey's Manual of Determinative Bacteriology - 9th ed. Williams & Wilkins, Baltimore, USA. 1994: 532.
  • National Committee For Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test - eighth ed. Approved standards: M2-A8. NCCLS, Wayne, Pennsylvania, USA 2003.
  • Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990; 28: 608–609.
  • National Committee For Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - sixth ed. Approved stan-dards. M7-A6. NCCLS, Wayne, Pennsylvania, USA 2003.
  • Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, SENTRY GROUP. Survey of infections due to Staphylococcus species: frequency of occur-rence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY antimicrobial surveil-lance program, 1997-1999. Clin Infect Dis 2001; 32 (suppl 2): S114-132.
  • Hiramatsu K. Vancomycin resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147–155.
  • Eltringham I. Mupirocin resistance and methicillin-resis-tant Staphylococcus aureus (MRSA). J Hosp Infect 1997; 35: 1–8.
  • Schitt KS, Knapp C, Hall G, Longworth DL, McMahon JT, Washington JA. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. J Clin Microbiol 1996; 34: 508–511
  • Herruzo-Cabrera R, Gracia-Torres V, Rey-Calero J, Vizcaino-Alcaide MJ. Evaluation of the penetration strength, bactericidal efficacy and spectrum of action of several antimi-crobial creams against isolated microorganisms in a burn cen-ter. Burns 1992; 18: 39–44.
  • Pirnay JP, Vos DD, Coches C et al. Molecular epi-demiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sul-fadiazine-resistant clone. J Clin Microbiol 2003; 41: 1192–1202.
  • Caelli M, Porteous J, Carson CF, Heller R, Riley TV. Tea tree oil as an alternative topical nasal decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000; 46: 236–237.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.